aspirin has been researched along with abt-737 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, LY; Lin, NM; Mao, SY; Pan, JP; Shi, J; Wang, SC; Xu, YS; Yan, YY; Yang, YP; Zhang, B; Zhang, C; Zhang, D | 1 |
Chen, CJ; Chen, WY; Kuan, YH; Li, JR; Liao, SL; Lu, HC; Ou, YC; Wang, JD; Yang, CP | 1 |
2 other study(ies) available for aspirin and abt-737
Article | Year |
---|---|
Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737.
Topics: Apoptosis; Aspirin; Autophagy; Biphenyl Compounds; Cell Line, Tumor; Humans; Neoplasms; Nitrophenols; p38 Mitogen-Activated Protein Kinases; Piperazines; Sulfonamides | 2015 |
Aspirin restores ABT-737-mediated apoptosis in human renal carcinoma cells.
Topics: Anticarcinogenic Agents; Apoptosis; Aspirin; Biphenyl Compounds; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Humans; Kidney Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Nitrophenols; Piperazines; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Sulfonamides | 2018 |